Search Results14 results found
CSL Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.
CSL Seqirus is one of the largest influenza vaccine companies in the world, with state-of-the-art manufacturing facilities on three continents. Learn more.
CSL Seqirus employs both egg and cell-based manufacturing systems to ensure the availability of our influenza vaccines. Learn more about our optimised technology.
Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.
Understand our aim to develop the next generation of influenza vaccines and how we're working to unite product platforms across the globe.
CSL Seqirus is working tirelessly to optimise our technology and implement transformational long-term approaches to influenza pandemic preparedness.
Collaborating to improve patient outcomes in Myanmar.
Code of Responsible Business Practice sets out the minimum standards for our employees to maintain high standards of business practice. Learn more.
CSL Seqirus is the largest fully integrated commercialisation partner in Australia and New Zealand. Learn more about our pharmaceutical partnership capabilities.
Meet Dr. Gregg Sylvester, Chief Health Officer at Seqirus.